Literature DB >> 12626604

Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients.

Jianhua Ni1, Edgardo Hembrador, Adrian M Di Bisceglie, Ira M Jacobson, Andrew H Talal, David Butera, Charles M Rice, Thomas J Chambers, Lynn B Dustin.   

Abstract

Chronic infection with hepatitis C virus (HCV) is associated with disturbances of B lymphocyte activation and function: autoantibody production, mixed cryoglobulinemia, and B cell lymphomas. It has been proposed that these abnormalities reflect chronic antigenic stimulation or aberrant signaling through the B cell coreceptor, the latter mediated by binding of the HCV E2 glycoprotein to CD81. To test this hypothesis, we measured expression of activation and differentiation markers on peripheral blood B cells from patients with chronic HCV infection. Thirty-six HCV patients with and without mixed cryoglobulinemia were compared with 18 healthy control volunteers and 17 sustained virologic responders who had cleared HCV infection. Ten of the 36 HCV patient samples showed increased B cell frequencies; B cell frequency was higher in patients with more severe hepatic fibrosis. However, these samples lacked evidence of Ag-driven activation or proliferation. The expanded cells were low in the activation markers CD25, CD69, CD71, CD80, and CD86. Proliferation of circulating B cells was unchanged in HCV patients. These cells did not express the differentiation marker CD27, suggesting that they were not enriched in memory B cells. Furthermore, the expanded B cells expressed both IgD and IgM, suggesting that they were antigenically naive. Together, these results indicate that B cell expansion in the peripheral blood of HCV patients is not associated with Ag-mediated activation and differentiation. Instead, factors other than antigenic stimulation may promote the accumulation of peripheral blood B cells with a naive phenotype in a subset of HCV patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626604     DOI: 10.4049/jimmunol.170.6.3429

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population.

Authors:  Hiroyoshi Doi; Tara K Iyer; Erica Carpenter; Hong Li; Kyong-Mi Chang; Robert H Vonderheide; David E Kaplan
Journal:  Hepatology       Date:  2012-01-19       Impact factor: 17.425

2.  The diversity of autoantibodies to P-ribosomal: the infectious-autoimmunity plot.

Authors:  Yehuda Shoenfeld
Journal:  J Mol Med (Berl)       Date:  2007-09       Impact factor: 4.599

3.  Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

Authors:  D Sansonno; G Lauletta; M Montrone; F A Tucci; L Nisi; F Dammacco
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

Review 4.  T-bet-expressing B cells during HIV and HCV infections.

Authors:  James J Knox; David E Kaplan; Michael R Betts
Journal:  Cell Immunol       Date:  2017-07-11       Impact factor: 4.868

5.  Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.

Authors:  David Butera; Svetlana Marukian; Amy E Iwamaye; Edgardo Hembrador; Thomas J Chambers; Adrian M Di Bisceglie; Edgar D Charles; Andrew H Talal; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

6.  Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.

Authors:  Domenico Rosa; Giulietta Saletti; Ennio De Gregorio; Francesca Zorat; Consuelo Comar; Ugo D'Oro; Sandra Nuti; Michael Houghton; Vincenzo Barnaba; Gabriele Pozzato; Sergio Abrignani
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

7.  Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules.

Authors:  Vito Racanelli; Maria Antonia Frassanito; Patrizia Leone; Maria Galiano; Valli De Re; Franco Silvestris; Franco Dammacco
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis.

Authors:  Hiroyoshi Doi; Shiroh Tanoue; David E Kaplan
Journal:  Clin Immunol       Date:  2013-12-17       Impact factor: 3.969

9.  Human herpesvirus-8 infection leads to expansion of the preimmune/natural effector B cell compartment.

Authors:  Silvia Della Bella; Adriano Taddeo; Elena Colombo; Lucia Brambilla; Monica Bellinvia; Fabrizio Pregliasco; Monica Cappelletti; Maria Luisa Calabrò; Maria Luisa Villa
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

10.  Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients.

Authors:  Korenori Ohtsubo; Michio Sata; Takumi Kawaguchi; Satoshi Morishige; Yuka Takata; Eijiro Oku; Rie Imamura; Ritsuko Seki; Michitoshi Hashiguchi; Koichi Osaki; Kazuaki Yakushiji; Taisuke Kanaji; Kohji Yoshimoto; Takato Ueno; Takashi Okamura
Journal:  Int J Hematol       Date:  2009-04-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.